Login / Signup

Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas.

Tomonori SekizakiHiraku KamedaAkinobu NakamuraSaki KuwabaraHiroshi NomotoKyu Yong ChoYukitomo IshiHiroaki MotegiHideaki MiyoshiTatsuya Atsumi
Published in: Pituitary (2023)
NMBR antagonist represents a potential treatment for CD and its effect may be mediated by cyclin E suppression.
Keyphrases
  • cell cycle
  • human health
  • risk assessment
  • cell proliferation
  • combination therapy
  • climate change
  • cell cycle arrest